| 20/12/2017 | Change of Substantial Holding Kroy Wen Pty Ltd |
| 18/12/2017 | Appendix 3Y – Change of Director’s Interest Notice RD |
| 18/12/2017 | Appendix 3Y – Change of Director’s Interest Notice MJ |
| 18/12/2017 | Appendix 3Y – Change of Director’s Interest Notice BS |
| 08/12/2017 | Change of Substantial Holding WG |
| 29/11/2017 | Rhinomed Completes AUD $3.6 Million Capital Raising |
| 27/11/2017 | Market Release – Trading Halt |
| 16/11/2017 | Change in Substantial Holding WG |
| 14/11/2017 | Results of General Meeting |
| 01/11/2017 | Company Announcement – Resignation of Joint Company Secretary |
| 31/10/2017 | Leading Wholesaler Phoenix Healthcare to Wholesale Mute in UK |
| 20/10/2017 | Completion of Test and Learn Program with Tier 1 US Retailer |
| 26/09/2017 | Corporate Governance Statement |
| 26/09/2017 | Rhinomed Board Charter |
| 26/09/2017 | Securities Trading Policy |
| 29/11/2017 | Successful Completion of Unmarketable Parcel Share Sale Program |
| 29/11/2017 | Rhinomed to Distribute Mute in Taiwan |
| 19/07/2017 | Leading USA Pharmacy Takes Mute into 4,300 Stores |
| 07/07/2017 | Major Expansion of Mute USA Retail Footprint |
| 06/07/2017 | Rhinomed Receives Regulatory Clearance for Taiwan |
| 05/07/2017 | Rhinomed – Less Than Marketable Parcel Sale Facility |
| 05/07/2017 | Letter to Small Shareholders |
| 20/06/2017 | Change of Address |
| 11/05/2017 | Capital Status Post Consolidation |
| 10/05/2017 | Appendix 3Y – Change of Director’s Interest Notice MJ |
| 10/05/2017 | Appendix 3Y – Change of Director’s Interest Notice EK |
| 10/05/2017 | Appendix 3Y – Change of Director’s Interest Notice BS |
| 08/05/2017 | Amcal and Guardian Core Range Mute Australia Wide |
| 03/05/2017 | Consolidation Timetable and ASX Code RNODC |
| 28/04/2017 | Results of Meeting |
| 24/04/2017 | Appendix 3Y – Change of Director’s Interest Notice RD |
| 06/04/2017 | Mute to go on Sale in Over 800 North American GNC Stores |
| 31/03/2017 | Expiry of Quoted Options (RNOOA) |
| 29/03/2017 | Notification of Consolidation Split |
| 29/03/2017 | Notice of General Meeting – To Consider All Capital Management Initiatives |
| 29/03/2017 | Notice of Change of Interests of Substantial Holder |
| 15/03/2017 | Rhinomed Receives $280k Research and Development Tax Refund |
| 15/03/2017 | Rhinomed Completes Successful Capital Raise |
| 15/03/2017 | Capital Management Initiatives |
| 13/03/2017 | Trading Halt Request |
| 13/03/2017 | Market Release – Trading Halt |
| 08/03/2017 | Mute Global Distribution Milestone Update |
| 07/03/2017 | Investor Newsletter – March 2017 |
| 30/01/2017 | Working Capital Facility Established |
| 18/01/2017 | Disclosure Policy and ASX Communication Committee Charter |
